And HHS defines exactly who will benefit from the Part D OOP cap
Plus a great news-you-can-use Consumer Reports piece
And I love that STAT did the math on PBM ad-war spending
And little bits on China, biosims white bagging and ... Gary Cooper (?)
And then we can all get back to buying fireworks
And Biomarin did a damn good job talking about price for its just-approved gene therapy
Plus some transparency news and a return to electorial politics, circa 2020
And Walgreens is pretty sanguine about 340B, plus the health economics of pickleball
And we remain on a collison course when it comes to paying for obesity treatment
I have movers in my kitchen, and my internet is about to be shut off, so it's a quick one today ...
And Stop Me if You've Heard This Before, But Drug Prices Are Falling
And Maybe Twitter Isn't The Wasteland I Thought It Was (For Docs, Anyway)
